Citations

Showing 10 of 108104 citations.

Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods
Munjal, Nupur S., Sapra, Dikscha , Parthasarathi, Kaushik , Goyal, Abhishek , Pandey, Akhilesh , Banerjee, Manidipa , Sharma, Jyoti , Pandey, Akhilesh , Parthasarathi, K. T. Shreya

Mayo Clinic

Pathogens | February 17, 2022 | Volume: 11 | Issue: 2 | Pages: 259

10.3390/pathogens11020259 | PMID 35215201 Get It

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is accountable for the protracted COVID-19 pandemic. Its high transmission rate and pathogenicity led to health emergencies and economic crisis. Recent studies pertaining to the understanding of the molecular pathogenesis of SARS-CoV-2 infection exhibited the indispensable role of ion channels in viral infection inside the host. Moreover, machine learning (ML)-based algorithms are providing a higher accuracy for host-SARS-CoV-2 protein–protein interactions (PPIs). In this study, PPIs of SARS-CoV-2 proteins with human ion channels (HICs) were trained on the PPI-MetaGO algorithm. PPI networks (PPINs) and a signaling pathway map of HICs with SARS-CoV-2 proteins were generated. Additionally, various U.S. food and drug administration (FDA)-approved drugs interacting with the potential HICs were identified. The PPIs were predicted with 82.71% accuracy, 84.09% precision, 84.09% sensitivity, 0.89 AUC-ROC, 65.17% Matthews correlation coefficient score (MCC) and 84.09% F1 score. Several host pathways were found to be altered, including calcium signaling and taste transduction pathway. Potential HICs could serve as an initial set to the experimentalists for further validation. The study also reinforces the drug repurposing approach for the development of host directed antiviral drugs that may provide a better therapeutic management strategy for infection caused by SARS-CoV-2.
Enterococcus durans Cardiac Implantable Electronic Device Lead Infection and Review of Enterococcus durans Endocarditis Cases
Radovanovic, Milan , Jevtic, Dorde , Barsoum, Michel K., Patel, Janki , Dumic, Igor , Jevtic, Djordje , Dumic, Igor

Mayo Clinic

Medicina | February 17, 2022 | Volume: 58 | Issue: 2 | Pages: 307

10.3390/medicina58020307 | PMID 35208630 Get It

Introduction: Cardiac implantable electronic device (CIED) infections present a growing problem in medicine due to a significant increase in the number of implanted devices and the age of the recipient population. Enterococcus spp. are Gram-positive, facultative anaerobic, lactic acid bacteria; they are relatively common pathogens in humans, but uncommon as the cause of CIED lead infections. Only eight cases of Enterococcus durans endocarditis have been reported in the literature thus far; however, there are no reported cases of Enterococcus durans CIED lead infection. Case presentation: A 58-year-old gentleman with a previously implanted St. Jude Medical single-chamber implantable cardioverter–defibrillator (ICD) due to tachy/brady arrhythmias presented with nonspecific constitutional symptoms (i.e., low-grade fevers, chills, fatigue), and was found to have innumerable bilateral pulmonary nodules via computed tomography angiography of the chest. Many of these pulmonary nodules were cavitated and highly concerning for septic pulmonary emboli and infarcts. Within 24 h from presentation, blood cultures in all four culture bottles grew ampicillin- and vancomycin-susceptible Enterococcus durans. Transthoracic echocardiogram confirmed vegetations on the ICD lead in the right ventricle. The patient underwent laser extraction of the ICD lead with generator removal and recovered completely after a 6-week intravenous antibiotic course. Conclusion: To our knowledge, this is the first report of CIED lead infection caused by Enterococcus durans. In this case, management with antibiotics along with ICD lead extraction led to complete recovery. Clinicians should be aware of this rare but potentially devastating infection in patients with native and artificial valves, but also in those with CIEDs.
Maintenance of NAD+ Homeostasis in Skeletal Muscle during Aging and Exercise
Ji, Li Li , Yeo, Dongwook

Mayo Clinic

Cells | February 17, 2022 | Volume: 11 | Issue: 4 | Pages: 710

10.3390/cells11040710 | PMID 35203360 Get It

Nicotinamide adenine dinucleotide (NAD) is a versatile chemical compound serving as a coenzyme in metabolic pathways and as a substrate to support the enzymatic functions of sirtuins (SIRTs), poly (ADP-ribose) polymerase-1 (PARP-1), and cyclic ADP ribose hydrolase (CD38). Under normal physiological conditions, NAD+ consumption is matched by its synthesis primarily via the salvage pathway catalyzed by nicotinamide phosphoribosyltransferase (NAMPT). However, aging and muscular contraction enhance NAD+ utilization, whereas NAD+ replenishment is limited by cellular sources of NAD+ precursors and/or enzyme expression. This paper will briefly review NAD+ metabolic functions, its roles in regulating cell signaling, mechanisms of its degradation and biosynthesis, and major challenges to maintaining its cellular level in skeletal muscle. The effects of aging, physical exercise, and dietary supplementation on NAD+ homeostasis will be highlighted based on recent literature.
The Challenge of Accurate Blood Pressure Measurement: Optimizing Cuff Size and Fit Is Important for All, Not Just for Some
Taler, Sandra J. , Brady, Tammy McLoughlin

Mayo Clinic

American Journal of Hypertension | February 17, 2022 | Volume: 35 | Issue: 6 | Pages: 503-505

10.1093/ajh/hpac026 | PMID 35182419 Get It

Randomized Trial of a Web-Based Tobacco Treatment and Online Community Support for People With HIV Attempting to Quit Smoking Cigarettes
Shuter, Jonathan, Chander, Geetanjali, Graham, Amanda L., Kim, Ryung S., Stanton, Cassandra A., Shuter, Jonathan, Chander, Geetanjali, Graham, Amanda L., Kim, Ryung S., Stanton, Cassandra A.

Mayo Clinic

JAIDS Journal of Acquired Immune Deficiency Syndromes | February 17, 2022 | Volume: 90 | Issue: 2 | Pages: 223-231

10.1097/qai.0000000000002936 | PMID 35175971 Get It

Background: Persons with HIV (PWH) in the United States (US) smoke cigarettes at approximately triple the rate of the general adult population and are less successful in their quit attempts than other smokers. This randomized trial tested whether a novel web-based cessation program for PWH yielded higher cigarette quit rates compared with a control program. Setting: Two urban HIV care sites in NYC and Baltimore. Methods: Between 2016 and 2020, 506 PWH were randomized to either Positively Smoke Free on the Web (PSFW+; N = 255), a multimodal platform, interactive web intervention hosted within an online social network to support quitting among PWH who smoke, and an attention-matched web-based control intervention (American Heart Association Getting Healthy; N = 251). All participants were offered 12 weeks of nicotine patch. Our primary outcome was biochemically confirmed exhaled carbon monoxide < 10 parts per million (ppm) 7-day point prevalence abstinence at 6 months. Results: Participants were middle-aged (mean 50.2 years; range 23–73 years), 57% male, 19% Latinx, 83% Black, and 13% White. At 6 months, a significantly greater percentage of PSFW+ participants (14.9%) achieved biochemically confirmed 7-day point prevalence abstinence in intent-to-treat analysis compared with 8.8% of American Heart Association Getting Healthy participants [odds ratio =1.82 (95% confidence interval =1.04 to 3.18), P = 0.03]. Conclusions: PSFW+ is a promising cessation intervention composed of empirically tested content and real-time social support through an online social network that was found to promote abstinence. This digital approach has broad reach and scalability, can be easily integrated into comprehensive HIV care, and represents an advance in the fight against tobacco use among PWH.
Immunotherapy with Alutard SQ reduced symptoms and need for medication in severe summer hay fever
Li, James T.C.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 114 | Issue: 3 | Pages: 81

10.7326/acpjc-1991-114-3-081 Get It

Carotid endarterectomy reduced death and strokes in patients with ipsilateral high-grade stenosis and recent hemispheric transient ischemic attacks or nondisabling strokes
Whisnant, Jack P.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 115 | Issue: 2 | Pages: 34

10.7326/acpjc-1991-115-2-034 Get It

Carotid endarterectomy reduced strokes in patients with recent, nondisabling cerebral ischemic events and severe carotid stenosis
Whisnant, Jack P.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 115 | Issue: 2 | Pages: 33

10.7326/acpjc-1991-115-2-033 Get It

Review: Meta-analysis shows that cholecystectomy is associated with a small increased risk for colorectal cancer of the proximal colon
Talley, Nicholas J.

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 120 | Issue: 1 | Pages: 25

10.7326/acpjc-1994-120-1-025 Get It

Cholecystectomy was not associated with the overall risk for colorectal cancer
Talley, Nicholas

Mayo Clinic

ACP Journal Club | February 17, 2022 | Volume: 120 | Issue: 1 | Pages: 24

10.7326/acpjc-1994-120-1-024 Get It